The Effects of Red Spinach Extract Supplementation on Isometric Strength, Resistance Exercise and Cognitive Performance
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04292106 |
Recruitment Status :
Completed
First Posted : March 2, 2020
Last Update Posted : January 14, 2022
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Sports | Dietary Supplement: Red Spinach Extract (RSE) Dietary Supplement: Placebo | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 11 participants |
Allocation: | Randomized |
Intervention Model: | Crossover Assignment |
Masking: | Double (Participant, Investigator) |
Primary Purpose: | Basic Science |
Official Title: | The Effects of Red Spinach Extract Supplementation on Isometric Strength, Resistance Exercise and Cognitive Performance. |
Actual Study Start Date : | September 26, 2019 |
Actual Primary Completion Date : | March 30, 2020 |
Actual Study Completion Date : | March 30, 2020 |
Arm | Intervention/treatment |
---|---|
Placebo Comparator: Placebo |
Dietary Supplement: Placebo
Oral placebo capsules will be taken consisting of maltodrextrin daily for 7 days |
Experimental: Red Spinach Extract (RSE) |
Dietary Supplement: Red Spinach Extract (RSE)
Oral capsules containing 2g of Red Spinach Extract will be consumed daily for 7 days |
- Bench Press Repetitions to Fatiuge [ Time Frame: Through study completion, during both treatments (~4 weeks) ]Number of repetitions completed in each set during the acute exercise bout will be recorded and analyzed
- Bench Press Power [ Time Frame: Through study completion, during both treatments (~4 weeks) ]Power during bench press repetitions will be measured via a linear transducer.
- Isometric Mid-thigh pull (IMTP) Peak Force [ Time Frame: Through study completion, during both treatments (~4 weeks) ]Peak Force will be measured via dual force plates during a full-body isometric strength test.
- Isometric Mid-thigh pull (IMTP) Rate of Force Development [ Time Frame: Through study completion, during both treatments (~4 weeks) ]Rate of Force development will be measured via dual force plates during a full-body isometric strength test.
- Estimated Muscle Blood Flow via Near-infrared Spectroscopy (NIRS) [ Time Frame: Through study completion, during both treatments (~4 weeks) ]Measures of muscle oxygenation of the anterior deltoid will be estimated using a NIRS Device.
- Cognitive Performance via Stroop Test [ Time Frame: Through study completion, during both treatments (~4 weeks) ]The Stroop Color and Word Test (SCWT) is a neuropsychological test used to assess cognitive performance. This will be administered before and after the fatiguing bench press protocol

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years to 34 Years (Adult) |
Sexes Eligible for Study: | Male |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- 18-34 years old Participants must have at least 1 year of resistance training experience.
- Free of any physical limitations, medications, and supplements that may affect performance, as determined by a health and activity questionnaire.
- Are free of musculoskeletal injuries
- Are not taking medications that may interfere with study measurements
Exclusion Criteria:
- Participants that cannot take either the RSE or placebo supplement will be excluded, as this will be a double-blind study.
- Furthermore, participants that cannot participate in pre- and post-research testing, and/or those that cannot commit to regular training sessions will be excluded.
- Inability to perform physical exercise (determined by health and activity questionnaire)
- Taking any other nutritional supplement or performance enhancing drug.
- Any chronic illness that causes continuous medical care

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04292106
United States, Tennessee | |
Jeremy Townsend | |
Nashville, Tennessee, United States, 37215 |
Principal Investigator: | Jeremy Townsend, PhD | Lipscomb University |
Responsible Party: | Jeremy Townsend, Assistant Professor, Lipscomb University |
ClinicalTrials.gov Identifier: | NCT04292106 |
Other Study ID Numbers: |
092619 |
First Posted: | March 2, 2020 Key Record Dates |
Last Update Posted: | January 14, 2022 |
Last Verified: | January 2022 |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |